Research

Burkitt lymphoma survival improves for some

Three-year survival trends by age and race/ethnicity

Relative survival rates compare Burkitt lymphoma patients to similar controls who do not have the disease. Improvements in survival were statistically significant for all groups except patients aged 60 and older, left, and blacks, right. Credit: Warren Alpert Medical School

Treatment advances have helped improve patient survival of Burkitt lymphoma, a highly aggressive cancer, but not among the elderly, patients at a late stage, or blacks. A new study, reported in the journal Cancer, uses those findings to develop a risk score that will help doctors, patients, families, and researchers better understand prognosis.